Skip to content
← Perspectives
5 min read

How to Prepare for New PBM Fee Disclosure Rules

Professional reviewing health insurance plan documents and PBM fee disclosures

The Department of Labor has published final regulations establishing comprehensive PBM fee disclosure requirements for self-insured group health plans. These rules demand that pharmacy benefit managers provide specific, itemized breakdowns of their compensation to plan fiduciaries to ensure compliance with ERISA standards.

Key Takeaways

  • New regulations force PBMs to disclose direct and indirect compensation in clear, non-jargon language.

  • Plan fiduciaries are responsible for reviewing these disclosures to determine if their PBM contract remains "reasonable" under ERISA.

  • Employers must prepare for new audit requirements, as plans now have the explicit right to conduct annual reviews of PBM records.

  • The rules apply specifically to large, self-insured plans, with implementation beginning in 2027.

What Do the New PBM Fee Disclosure Requirements Change?

According to the Law Offices of Snell & Wilmer, the Department of Labor (DOL) has finalized regulations that hold PBMs accountable for providing granular data on their fee structures. For years, many employers have struggled to untangle the "black box" of pharmacy benefits, where rebates, spread pricing, and administrative fees often obscure the true cost of care.

The core of this mandate is simple: PBMs serving self-insured plans must now disclose their compensation in a format that a fiduciary can actually understand. Gone are the days when generic industry terms could mask specific dollar amounts. PBMs are now required to report compensation as actual dollar amounts, not just vague percentages or estimated ranges, and they must provide this information in machine-readable files upon request.

Understanding Fiduciary Responsibility Under the New Rules

Under ERISA Section 408(b)(2), plan fiduciaries have a legal obligation to ensure that the contracts they sign—including those with PBMs—are reasonable in terms of cost and service. Historically, determining "reasonableness" in a pharmacy contract was nearly impossible because the data was hidden behind proprietary confidentiality clauses.

The new rules change this dynamic. If a PBM refuses to provide the required data, or if the data provided is too opaque to evaluate, the contract itself may fail the "reasonable" test. This places the burden squarely on the employer to actively manage their PBM relationship. You cannot simply sign an agreement and assume compliance; you must now document that you have received, reviewed, and questioned the compensation data provided by your vendor.

Preparing for PBM Audits and Transparency

One of the most significant shifts in the final rule is the codification of the plan fiduciary’s right to perform annual audits. Previously, many PBM contracts included restrictive language that made meaningful audits difficult or prohibitively expensive. The new regulations override this by ensuring that the plan—and only the plan—selects the auditor, and the PBM must provide access to transaction-level data within 60 days of a request.

For HR and finance leaders, this means it is time to review your current client service agreements. You should look for:

  • Audit Access:

    Does your current contract limit your ability to access drug manufacturer and pharmacy contracts?

  • Reporting Cadence:

    Are you currently receiving data semiannually or quarterly, or is your PBM operating on a less frequent schedule?

  • Definitions:

    Are the fee structures in your current documents written in plain English, or do they rely on "generic industry terms" that the new rule now prohibits?

Comparative Overview: Current vs. Future PBM Reporting

Feature Historical PBM Practice Post-2027 Requirements Compensation Format Vague, bundled percentages Clear, itemized dollar amounts Data Accessibility Restricted by confidentiality Machine-readable, transparent files Audit Rights Limited or contract-dependent Mandatory annual access to records Fiduciary Liability Often ignored/not enforced Direct responsibility to review fees

Next Steps for HR and Finance Leaders

You do not need to wait until the 2027 effective date to begin preparing. In our experience, the most effective way to address these changes is to start by auditing your existing relationship today. If your PBM cannot provide a clear, line-item breakdown of their revenue sources now, they are likely behind the curve on the upcoming compliance requirements.

We often see employers caught in the middle of self-funded vs. fully insured decisions without realizing how PBM transparency affects their long-term health plan costs. Whether you are managing your plan through a PEO or managing your benefits administration in-house, your fiduciary duty remains. Proactive engagement with your PBM ensures you stay ahead of these regulatory requirements rather than reacting to them when a conflict arises.

Frequently Asked Questions

What is the primary goal of the new PBM fee disclosure requirements?

The new rules aim to ensure that plan fiduciaries have clear, accurate, and itemized data regarding the compensation PBMs receive. This transparency allows employers to evaluate the reasonableness of their pharmacy benefit arrangements and ensure they are fulfilling their fiduciary duties under ERISA.

Which employers must comply with the new PBM disclosure rules?

The rules apply to self-insured group health plans sponsored by "specified large employers" or plans with 100 or more participants. Fully insured plans and plans affiliated with PBMs or drug manufacturers are generally excluded from this specific regulation.

When do these new PBM transparency regulations take effect?

The final rule applies to plan years beginning on or after July 1, 2027, with a start date of January 1, 2028, for calendar-year plans. Additional reporting requirements under the Consolidated Appropriations Act take effect in late 2028 and early 2029.

What happens if a PBM fails to provide the required disclosures?

If a PBM fails to provide the mandated disclosures, the underlying service agreement may no longer qualify as a "reasonable contract" under ERISA. This can trigger a prohibited transaction, creating potential liability for both the plan fiduciary and the PBM.

Evaluate Your PBM Transparency Today

As these new rules take shape, many employers are finding that their current PBM agreements were built for a less transparent era. If you need assistance evaluating your plan's workforce management and benefits strategy to ensure you meet your fiduciary obligations, our team is available to help. You can reach out to a BRG advisor to discuss how these changes specifically impact your organization.

This article is general operational guidance, not legal advice. Requirements change, so confirm current rules with qualified counsel before acting.

If this resonates, book a live discussion.

Where to go from here

The mechanics behind this piece, and the engagements where it played out.

Get started

Let’s have the conversation.

A direct, no-pressure discussion to see whether we’re the right fit. No proposal, no pitch.